DEK and breast cancer: For example, miR-489 has been shown to directly target other oncogenes such as Shp2 in HSCC [18], SMAD3 in breast cancer [19], AKT3 in ovarian cancer [36] and Dek in mouse muscle stem cells [17, 36].